middl
east
respiratori
syndrom
emerg
viral
respiratori
infect
caus
middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
saudi
arabia
novel
coronaviru
associ
sever
pneumonia
acut
respiratori
distress
syndrom
ard
often
result
mortal
alsaad
et
al
arabi
et
al
ng
et
al
case
death
report
twentyseven
countri
decemb
geograph
link
middl
east
though
sporad
infect
small
nosocomi
outbreak
continu
occur
across
arabian
peninsula
potenti
global
transmiss
demonstr
outbreak
south
korea
spread
singl
infect
individu
return
arabian
peninsula
result
confirm
case
mortal
rate
lee
current
treatment
merscov
reli
support
treatment
symptom
potenti
merscov
therapeut
countermeasur
gradual
progress
toward
clinic
trial
develop
therapeut
strategi
hinder
poor
understand
viral
pathogenesi
human
creat
challeng
develop
applic
anim
model
resembl
human
diseas
outcom
recent
two
case
report
describ
patholog
consequ
observ
merscov
infect
patient
alsaad
et
al
ng
et
al
nonhuman
primat
nhp
offer
advantag
preclin
therapeut
test
due
physiolog
similar
human
two
nhp
model
rhesu
macaqu
marmoset
shown
support
merscov
infect
howev
limit
regard
abil
detect
replic
merscov
lung
extent
respiratori
diseas
appear
vari
mildtosever
laboratori
depend
manner
chan
et
al
falzarano
et
al
johnson
et
al
johnson
et
al
munster
et
al
importantli
may
consequ
difficulti
establish
merscov
infect
lower
respiratori
tract
dipeptidyl
peptidas
receptor
predominantli
express
human
respiratori
tract
meyerholz
et
al
potenti
speciesspecif
differ
signal
mechan
may
impact
product
high
titer
merscov
complex
establish
infect
nhp
suggest
merscov
may
adapt
elicit
sever
respiratori
diseas
often
associ
human
infect
merscov
adapt
repeat
passag
within
nhp
speci
may
help
enhanc
virul
replic
sever
human
diseas
reliabl
nhp
speci
adapt
shown
previous
success
establish
merscov
infect
elicit
lethal
respiratori
diseas
two
human
mous
model
cockrel
et
al
li
et
al
cluster
regularli
interspac
short
palindrom
repeat
crisprassoci
gene
technolog
make
amino
acid
substitut
posit
gener
human
mous
model
support
high
level
viru
replic
fifteen
serial
passag
viru
heterozyg
mice
result
mouseadapt
viru
capabl
achiev
dramat
weight
loss
sever
lung
patholog
lethal
respiratori
diseas
mice
importantli
minim
chang
preclud
disrupt
innat
role
glucos
homeostasi
immun
dysregul
ohnuma
et
al
rohrborn
et
al
replic
clinic
diseas
also
preserv
hostspecif
express
pattern
immun
function
human
mous
model
offer
use
tool
studi
pathogenesi
therapeut
test
limit
viru
high
dose
pfu
requir
produc
sever
respiratori
diseas
intranas
rout
infect
cockrel
et
al
wherea
merscov
mous
model
demonstr
diseas
could
achiev
lower
infecti
dose
coleman
et
al
li
et
al
evid
merscov
infect
patient
indic
may
associ
viru
dose
sever
respiratori
diseas
oh
et
al
initi
diseas
natur
acquisit
merscov
may
also
dose
depend
therefor
achiev
dose
close
resembl
natur
acquir
infect
continu
adapt
evolut
mice
gener
novel
mouseadapt
merscov
clone
confer
patholog
indic
sever
respiratori
diseas
substanti
lower
dose
mice
mouseadapt
caus
patholog
similar
exhibit
dosedepend
effect
pfu
identifi
uniqu
mutat
clone
may
promot
sever
respiratori
diseas
fold
lower
viru
dose
previous
observ
notabl
compar
genet
provid
us
distinct
advantag
allow
us
identifi
mutat
remain
fix
addit
passag
implic
import
confer
virul
mice
merscov
mouseadapt
serial
passag
lung
heterozyg
mice
previous
describ
cockrel
et
al
fatal
diseas
routin
observ
pfu
dose
cockrel
et
al
potenti
limit
could
overcom
continu
passag
lung
mice
cockrel
et
al
demonstr
continu
passag
viru
lung
mice
yield
mouseadapt
mer
strain
exhibit
dramat
weight
loss
passag
respect
refer
two
heterogen
mouseadapt
merscov
popul
expand
vero
cell
test
pfu
dose
intranas
inocul
mice
fig
signific
weight
loss
observ
day
postinfect
pi
two
differ
dose
mouseadapt
exhibit
signific
weight
loss
pfu
pfu
averag
weight
loss
dose
fig
notabl
mice
euthan
approach
weight
exclus
limit
anticip
mice
would
succumb
diseas
later
time
postinfect
contrast
mice
infect
reach
weight
loss
fig
indic
may
less
virul
despit
differ
diseas
sever
increas
passag
result
two
novel
merscov
heterogen
viru
popul
elicit
weight
loss
commonli
associ
sever
respiratori
diseas
data
indic
novel
viru
genet
mutat
acquir
addit
round
adapt
mice
gain
insight
genet
chang
plaqu
purif
use
isol
novel
clone
virul
clonal
isol
deriv
plaqu
purifi
viru
vero
cell
mice
intranas
infect
three
differ
dose
pfu
fig
sever
weight
loss
associ
pfu
day
pi
littl
weight
loss
pfu
dose
fig
signific
mortal
succumb
diseas
cours
experi
observ
pfu
dose
wherea
anim
surviv
day
pi
pfu
dose
fig
graph
surviv
weight
loss
demonstr
decreas
surviv
pfu
dose
supplementari
fig
howev
mice
euthan
mice
receiv
pfu
dose
approach
weight
exclus
limit
base
result
would
suggest
ld
pfu
dramat
weight
loss
mortal
correl
well
sever
respiratori
diseas
quantifi
gross
investig
hemorrhag
lung
day
postinfect
fig
lung
score
hemorrhag
scale
hemorrhag
sever
hemorrhag
throughout
lung
lobe
earli
infect
day
pi
hemorrhag
score
correl
dose
viru
administ
fig
compar
minor
hemorrhag
pfu
infecti
dose
elicit
signific
hemorrhag
day
pi
fig
day
pi
pfu
dose
invok
dramat
hemorrhag
across
lung
lobe
fig
interestingli
although
minim
weight
loss
occur
mice
infect
pfu
dose
substanti
lung
hemorrhag
observ
day
pi
indic
dose
caus
signific
lung
diseas
fig
viral
load
lung
consist
diseas
elicit
differ
dose
fig
day
pi
replic
high
titer
pfumlgram
lung
tissu
lung
dose
mean
lung
titer
increas
increas
dose
fig
titer
day
pi
exhibit
dosedepend
effect
clearanc
lung
fig
mice
infect
pfu
dose
show
littl
detect
viru
day
pi
higher
titer
persist
mice
infect
pfu
dose
fig
weight
loss
mortal
hemorrhag
viral
load
lung
consist
dosedepend
effect
merscovinduc
diseas
lung
diseas
gross
hemorrhag
observ
dose
low
pfu
indic
infect
elicit
dramat
patholog
chang
lung
architectur
merscov
viral
load
lung
infect
human
exhibit
phase
correl
develop
respiratori
diseas
viral
load
peak
earli
infect
viral
load
begin
decreas
symptom
associ
respiratori
diseas
increas
oh
et
al
similar
correl
observ
follow
infect
mice
mouseadapt
reach
peak
viral
load
shortli
infect
day
pi
began
resolv
late
time
postinfect
day
pi
fig
fig
merscov
nucleocapsid
antigen
stain
immunohistochemistri
reveal
widespread
infect
lung
day
pi
three
dose
substanti
clearanc
day
affect
parenchyma
airway
epithelium
fig
tabl
correspond
well
dosedepend
effect
viral
load
lung
fig
consist
viral
replic
peak
earli
day
pi
initi
sign
lung
patholog
mouseadapt
exhibit
signific
respiratori
diseas
low
infecti
dose
mice
infect
intranas
n
black
triangl
n
blue
squar
n
red
circl
pfu
mice
monitor
daili
weight
loss
surviv
b
sever
hemorrhag
score
scale
hemorrhag
complet
hemorrhag
c
lung
titer
measur
mice
infect
dose
day
pi
n
day
pi
n
dose
day
pi
n
day
pi
n
dose
day
pi
n
day
pi
n
data
repres
mean
sem
lung
titer
limit
detect
valu
set
depict
mice
graph
virolog
observ
day
pi
tabl
ardsrel
patholog
chang
preval
day
pi
fig
tabl
chang
lung
architectur
dramat
mice
infect
pfu
fig
quantit
assess
hyalin
membran
format
exhibit
clear
dose
relat
phenotyp
dramat
diseas
exhibit
pfu
dose
tabl
low
magnif
imag
larg
airway
show
denud
epitheli
cell
layer
view
lefttoright
debri
airway
sever
polynuclear
infiltr
alveoli
alveoli
duct
hyalin
membran
format
reflect
mani
exhibit
patholog
note
human
case
sever
acut
respiratori
distress
syndrom
fig
although
hyalin
membran
format
less
frequent
mice
pfu
dose
sever
inflamm
intraalveolar
edema
denud
larg
airway
cellular
debri
larg
airway
readili
observ
consist
dramat
gross
hemorrhag
observ
pfu
pfu
dose
fig
red
blood
cell
frequent
detect
larg
airway
alveolar
space
fig
f
h
interestingli
despit
mild
weight
loss
observ
pfu
dose
fig
mice
exhibit
respiratori
patholog
consist
respiratori
diseas
includ
intraalveolar
edema
perivascular
cuf
sever
inflamm
fig
k
tabl
although
mani
area
display
normal
lung
morpholog
fig
result
indic
elicit
dosedepend
patholog
chang
primarili
hyalin
membran
format
lower
respiratori
tract
reflect
loss
respiratori
function
commensur
weight
loss
increas
mortal
increas
hemorrhag
lung
infect
mice
achiev
dramat
diseas
lesser
extent
pfu
demonstr
sever
respiratori
diseas
compar
seen
pfu
suggest
acquir
addit
mutat
enhanc
virul
sequenc
genom
plaqu
purifi
reveal
sever
uniqu
mutat
acquir
serial
passag
includ
singl
nucleotid
chang
utr
singl
amino
acid
chang
nonstructur
protein
tabl
novel
singl
amino
acid
chang
also
observ
spike
protein
membran
protein
tabl
addit
acquir
larg
delet
extend
begin
tabl
though
uniqu
mutat
utr
spike
protein
also
present
previous
adapt
viru
cockrel
et
al
notabl
mutat
remain
addit
round
adapt
achiev
viru
spike
insert
rmr
spike
mutat
tabl
cockrel
et
al
implic
mutat
critic
elicit
respiratori
diseas
mous
model
although
mutat
differ
viru
acquir
novel
mutat
viral
genet
domain
implic
import
region
merscov
elicit
respiratori
diseas
mous
model
contrast
mutat
acquir
indic
function
expend
elicit
respiratori
diseas
importantli
spike
mutat
notabl
similar
mutat
acquir
mouseadapt
merscov
describ
recent
studi
li
et
al
sequenc
result
demonstr
spike
mutat
highli
conserv
mouseadapt
strain
lab
insert
rmr
well
strain
lab
li
et
al
conserv
natur
mouseadapt
mutat
prompt
us
investig
potenti
alter
structur
featur
merscov
spike
use
structur
predict
softwar
place
mutat
context
spike
trimer
homolog
base
structur
model
use
understand
conserv
mouseadapt
spike
mutat
may
influenc
structur
merscov
trimer
place
prefus
spike
trimer
determin
yuan
et
al
use
cryoem
spike
mutat
identifi
studi
mutat
identifi
li
et
al
compar
domain
spike
emc
fig
spike
mutat
indic
fig
tabl
place
onto
monom
merscov
spike
trimer
fig
use
freeli
avail
predict
softwar
netnglyc
server
seem
like
put
glycosyl
site
though
mutat
occur
posit
mutat
ntermin
domain
replac
polar
amino
acid
n
nonpolar
uncharg
residu
appear
result
slight
structur
modif
wherea
structur
featur
appear
maintain
context
neg
charg
residu
fig
also
highlight
trimer
spike
structur
rmr
insert
spike
mutat
domain
fig
conserv
across
strain
interestingli
rmrl
mutat
red
directli
overlap
part
fusion
domain
yellow
appar
alter
furin
cleavag
site
millet
whittak
fig
green
use
freeli
avail
furin
cleavag
site
predict
softwar
prop
server
determin
insert
rmr
like
gener
novel
furin
cleavag
site
mouseadapt
mutat
spike
may
import
implic
regard
enhanc
viral
replic
determin
tropism
ardslik
respiratori
diseas
like
depend
combin
spike
mutat
conserv
mutat
identifi
merscov
genet
loci
studi
found
extend
passag
merscov
mice
enhanc
virul
achiev
sever
respiratori
diseas
fold
lower
dose
seen
earlier
passag
virus
cockrel
et
al
continu
adapt
evolut
addit
round
gener
capabl
elicit
compar
level
diseas
significantli
lower
dose
pfu
abil
use
lower
challeng
dose
like
reflect
merscov
infect
human
nosocomi
transmiss
primari
sourc
outbreak
review
importantli
individu
older
andor
comorbid
eg
diabet
hypertens
etc
higher
risk
sever
diseas
therefor
individu
present
preexist
condit
may
suscept
diseas
lower
viral
dose
recent
studi
demonstr
patient
room
environ
eg
bed
sheet
bed
rail
iv
fluid
hanger
radiographi
cassett
anteroom
tabl
healthcar
set
readili
contamin
replic
compet
merscov
bin
et
al
merscov
detect
numer
addit
surfac
rtpcr
indic
contamin
throughout
patient
room
bin
et
al
although
clear
dose
viru
necessari
establish
infect
diseas
human
unlik
low
dose
contamin
environment
sourc
contribut
hospit
transmiss
thu
evalu
broad
rang
dose
option
mous
model
afford
us
uniqu
abil
investig
least
three
independ
line
research
vari
infecti
dose
influenc
merscov
pathogenesi
ii
therapeut
efficaci
differ
infecti
dose
iii
compar
genet
differ
mouseadapt
strain
investig
merscov
genet
correl
respiratori
diseas
compar
genet
mouseadapt
viru
passag
passag
provid
insight
adapt
evolut
augment
virul
merscov
mous
model
addit
number
novel
mutat
identifi
specif
mutat
viru
remain
conserv
addit
passag
may
instrument
confer
sever
respiratori
diseas
mice
furthermor
identifi
missens
mutat
site
spike
protein
independ
identifi
differ
model
adapt
evolut
li
et
al
implic
site
central
enhanc
merscov
pathogenesi
mous
also
observ
mutat
multipl
nonstructur
protein
structur
protein
sever
orf
may
influenc
merscov
pathogenesi
enhanc
viral
fidel
andor
evas
host
immun
respons
genom
region
conserv
throughout
coronavirida
famili
encod
nonstructur
protein
nsp
compos
replic
transcript
complex
mouseadapt
acquir
uniqu
mutat
sever
nonstructur
protein
includ
includ
novel
missens
mutat
compar
curious
mutat
remain
fix
follow
addit
round
adapt
evolut
isoleucin
leucin
mutat
could
consid
minor
exchang
two
hydrophob
residu
may
littl
impact
function
fidel
process
especi
consid
hydrophob
residu
posit
conserv
across
mani
coronavirus
see
align
subissi
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
demonstr
form
tripartit
complex
confer
process
rna
synthes
activ
subissi
et
al
interact
found
critic
rnadepend
rna
polymeras
activ
subissi
et
al
time
clear
whether
mutat
impact
viru
process
alter
pathogenesi
merscov
mechan
exampl
subissi
et
al
also
demonstr
tripartit
complex
associ
augment
fidel
viral
replic
command
proofread
mechan
exoribonucleas
activ
subissi
et
al
addit
identifi
missens
mutat
domain
number
studi
investig
impact
mutat
across
coronaviru
replic
review
snijder
et
al
although
clear
whether
mutat
pfu
pfu
pfu
fig
mouseadapt
elicit
patholog
associ
ard
repres
imag
acquir
mous
lung
infect
dose
ad
eh
il
pfu
day
pi
imag
reflect
sever
diseas
observ
differ
dose
includ
denud
larg
airway
h
debri
airway
f
h
hyalin
membran
ae
red
blood
cell
larg
airway
alveoli
c
f
h
edema
c
g
k
perivascular
cuf
j
normal
region
mous
lung
pfu
dose
shown
l
imag
captur
magnif
imag
acquir
magnif
imag
repres
least
sampl
scale
bar
lower
right
corner
panel
mm
influenc
merscov
pathogenesi
futur
studi
warrant
investig
role
chang
diseas
although
missens
mutat
novel
studi
differ
mutat
identifi
viru
cockrel
et
al
implic
import
merscov
genet
locu
acquir
mutat
adapt
evolut
mice
protein
sarscov
demonstr
involv
format
doublemembran
vesicl
dmv
anchor
membranebound
replic
complex
angelini
et
al
lundin
et
al
recent
demonstr
inhibitor
select
target
dmv
format
infect
cell
select
resist
mutat
lundin
et
al
also
inhibit
merscov
replic
vitro
lundin
et
al
mutat
might
enhanc
viru
replic
pathogenesi
vivo
requir
addit
studi
evalu
effect
mouseadapt
mutat
compar
wildtyp
subject
futur
vitro
vivo
studi
mouseadapt
reveal
two
novel
missens
mutat
protein
multidomain
protein
multipl
function
indic
sarscov
baezsanto
et
al
use
sarscov
model
guid
mutat
like
resid
catalyt
activ
domain
adrp
domain
aka
macro
domain
x
domain
baezsanto
et
al
mutat
would
resid
domain
toward
carboxi
terminu
baezsanto
et
al
domain
remain
larg
uncharacter
except
crystal
structur
adrp
domain
solv
sarscov
vitro
assay
confirm
phosphatas
activ
egloff
et
al
saikatendu
et
al
moreov
mutat
catalyt
domain
adrp
alter
pathogenesi
replic
suggest
mutat
may
play
import
role
virushost
interact
diseas
fehr
et
al
importantli
data
support
discoveri
mutat
independ
identifi
differ
mouseadapt
merscov
li
et
al
independ
verif
strongli
suggest
mutat
nsp
play
critic
role
merscov
pathogenesi
develop
sever
respiratori
diseas
clearli
panel
recombin
virus
need
unravel
role
nsp
mutat
viru
replic
pathogenesi
vivo
primari
determin
merscov
tropism
chang
spike
protein
particular
interest
evalu
mouseadapt
coronavirus
note
spike
protein
includ
missens
mutat
put
glycosyl
site
similarli
li
et
al
also
observ
mutat
posit
structur
predict
show
minor
differ
structur
modif
two
mutant
fig
although
chang
nonpolar
uncharg
tyrosin
residu
neg
charg
aspart
acid
residu
may
differ
function
consequ
common
theme
independ
acquir
mutat
loss
put
glycosyl
site
posit
posit
resid
ntermin
domain
structur
distinct
receptor
bind
domain
fig
major
determin
viral
tropism
interact
hulswit
et
al
recent
studi
shown
coronaviru
domain
fold
fig
structur
model
spike
mutat
emc
align
amino
acid
sequenc
identifi
domain
emc
color
correspond
amino
acid
sequenc
chang
ntermin
domain
ntd
magenta
blue
compar
emc
orang
domain
rmr
insert
mutat
red
compar
wildtyp
sequenc
emc
green
fusion
domain
region
highlight
yellow
vari
shade
light
gray
black
diagram
correspond
color
scheme
depict
spike
trimer
b
b
structur
model
merscov
monom
conduct
use
onlin
model
softwar
trimer
construct
use
pymol
molecular
graphic
system
respect
mutat
identifi
within
spike
incorpor
model
structur
addit
mutat
visibl
surfac
structur
shown
c
expand
view
structur
region
observ
near
fusion
domain
emc
c
region
ntd
encompass
amino
acid
emc
virolog
distinct
subdomain
refer
kirchdoerf
et
al
wall
et
al
mutat
posit
within
subdomain
recent
demonstr
support
predomin
interact
host
sialic
acid
rel
interact
sialic
acid
li
et
al
distribut
host
sialic
acid
residu
human
camel
correl
merscov
infect
lower
upper
respiratori
tract
respect
speci
li
et
al
widagdo
et
al
propos
sialic
acid
residu
may
facilit
initi
low
affin
interact
cell
prior
high
affin
interact
rbd
b
host
receptor
li
et
al
elimin
put
glycosyl
site
adapt
evolut
mous
may
influenc
initi
interact
sialic
acid
residu
possibl
enhanc
infect
expand
host
cell
tropism
domain
proteolyt
separ
domain
furin
cleavag
interfac
millet
whittak
second
furin
cleavag
site
thought
cleav
upon
viral
entri
refer
millet
whittak
mouseadapt
rmr
insert
mutat
domain
mer
spike
mutat
origin
acquir
passag
murin
nih
cell
tissu
cultur
cockrel
et
al
remain
fix
round
adapt
evolut
mous
place
mutat
context
merscov
spike
trimer
demonstr
mutat
disrupt
canon
cleavag
site
emc
nonetheless
use
cleavag
site
predict
softwar
appear
mutat
creat
novel
furin
recognit
site
previous
demonstr
merscov
strain
harbor
mutat
replic
faster
kinet
tissu
cultur
higher
titer
emc
mous
lung
cockrel
et
al
suspect
novel
furin
cleavag
site
amen
process
mous
furin
therebi
enhanc
kinet
viral
replic
remain
test
importantli
mutat
alon
suffici
elicit
respiratori
diseas
even
high
pfu
viral
dose
cockrel
et
al
therefor
combin
mouseadapt
mutat
may
necessari
elicit
sever
respiratori
diseas
number
studi
implic
merscov
accessori
orf
protein
potenti
antagonist
innat
immun
respons
matthew
et
al
menacheri
et
al
rabouw
et
al
thornbrough
et
al
yang
et
al
yang
et
al
identifi
larg
delet
extend
begin
essenti
elimin
express
protein
li
et
al
also
identifi
larg
delet
well
number
orf
delet
mouseadapt
virus
li
et
al
express
also
elimin
sinc
nonsens
mutat
identifi
end
protein
addit
identifi
missens
mutat
outsid
put
rna
bind
domain
consid
accessori
orf
appear
express
much
appear
dispens
merscov
pathogenesi
mous
lung
nonetheless
menacheri
et
al
demonstr
use
infecti
clone
viru
complet
delet
orf
result
attenu
mice
menacheri
et
al
combin
observ
data
current
isol
specul
may
act
strong
interferon
antagonist
mice
facilit
develop
sever
respiratori
diseas
interestingli
merscov
isol
also
obtain
human
patient
delet
albeit
amino
acid
delet
lamer
et
al
vitro
studi
also
demonstr
merscov
protein
may
function
interferon
antagonist
lui
et
al
yang
et
al
n
termin
region
sarscov
merscov
protein
shown
suffici
inhibit
interferon
express
lui
et
al
siu
et
al
case
merscov
nterminu
protein
found
interact
disrupt
associ
lead
activ
lui
et
al
identifi
missens
mutat
nterminu
protein
li
et
al
also
identifi
missens
mutat
nterminu
protein
mouseadapt
merscov
missens
mutat
nterminu
sarscov
protein
also
associ
increas
pathogenesi
mice
robert
et
al
enhanc
viru
product
follow
adapt
tissu
cultur
pacciarini
et
al
taken
togeth
studi
impli
merscov
sarscov
may
share
conserv
function
resid
protein
nterminu
may
contribut
pathogenesi
mice
develop
robust
mous
model
merscov
pathogenesi
recapitul
lethal
end
stage
lung
phenotyp
low
dose
challeng
addit
achiev
low
challeng
dose
continu
adapt
evolut
identifi
conserv
novel
mutat
throughout
merscov
genom
may
function
implic
regard
phenotyp
observ
infect
futur
studi
includ
gener
merscov
infecti
clone
contain
mutat
confirm
observ
diseas
phenotyp
infecti
dose
describ
studi
subsequ
gener
novel
virus
differ
combin
mutat
evalu
role
replic
sever
respiratori
diseas
diseas
patholog
replic
mani
end
stage
lung
diseas
phenotyp
seen
human
model
valuabl
evalu
pathogen
mechan
merscov
host
immun
respons
merscov
use
therapeut
vaccin
revers
diseas
signatur
unless
otherwis
indic
detail
follow
head
found
cockrel
et
al
mainten
prepar
cell
viru
stock
found
cockrel
et
al
infect
done
previous
describ
mice
cockrel
et
al
briefli
sinc
mice
novel
mous
line
develop
bred
baric
lab
experi
util
avail
male
femal
mice
rang
week
age
mice
randomli
includ
cohort
indic
time
point
mous
studi
execut
condit
prior
viral
infect
mice
anesthet
administ
ketaminexylazin
mixtur
intraperiton
infect
intranas
volum
viru
indic
dose
follow
sedat
infect
mice
monitor
daili
weight
loss
surviv
well
sign
anim
moribund
includ
labor
breath
lack
movement
lack
groom
mice
reach
weight
loss
place
except
monitor
least
three
time
daili
mice
approach
weight
loss
immedi
euthan
mice
deem
moribund
euthan
discret
research
mice
euthan
isofluran
overdos
follow
secondari
thoracotomi
time
point
indic
result
collect
lung
tissu
method
approv
method
institut
anim
care
use
committe
iacuc
univers
north
carolina
chapel
hill
mous
studi
carri
accord
recommend
care
use
anim
offic
laboratori
anim
welfar
nih
iacuc
uncch
approv
anim
studi
perform
protocol
iacuc
use
weight
loss
cutoff
point
human
euthanasia
continu
adapt
heterozyg
mice
gof
research
consider
involv
merscov
vivo
passag
mice
review
approv
fund
agenc
nih
award
period
passag
experi
execut
award
period
passag
mous
lung
mice
continu
infecti
clone
refer
describ
previous
cockrel
et
al
passag
continu
addit
time
establish
isol
respect
clonal
isol
viru
obtain
plaqu
purif
amplif
vero
cell
confirm
clonal
isol
elicit
sign
indic
respiratori
diseas
rna
extract
lung
infect
mous
sequenc
rtpcr
briefli
rna
extract
lung
accord
manufactur
instruct
trizol
reagent
invitrogen
revers
transcript
reaction
perform
use
superscript
iii
firststrand
synthesi
system
rtpcr
invitrogen
follow
amplif
phusion
high
fidel
dna
polymeras
new
england
biolad
accord
manufactur
instruct
obtain
end
cap
viral
rna
use
firstchoic
rlmrace
kit
thermofish
accord
manufactur
instruct
sequenc
outsourc
offsit
eurofin
genom
character
mouseadapt
strain
execut
fold
lower
titer
indic
previous
use
strain
lung
tissu
section
process
stain
lineberg
comprehens
cancer
center
anim
histopatholog
core
facil
uncch
previous
describ
cockrel
et
al
quantit
data
present
mean
sem
signific
specif
data
set
describ
respect
figur
legend
determin
multipl
student
ttest
function
graphpad
prism
sinc
function
use
make
singl
comparison
indic
group
correct
multipl
comparison
use
alpha
valu
set
definit
statist
signific
spike
sequenc
merscov
emc
genbank
access
number
li
et
al
analyz
use
protein
homologyanalog
recognit
engin
server
kelley
et
al
submit
sequenc
includ
note
mutat
ntermin
domain
furin
cleavag
site
monomer
spike
subunit
model
merscov
trimer
base
prefus
structur
rcsb
pdb
id
yuan
et
al
use
pymol
molecular
graphic
system
version
schroding
llc
model
predict
protein
homologyanalog
recognit
engin
server
valid
use
differ
softwar
includ
mpi
bioinformat
toolkit
swissmodel
server
sib
bioinformat
resourc
portal
due
redund
model
model
base
upon
phyre
softwar
includ
manuscript
detail
descript
avail
cockrel
et
al
regard
continu
gainoffunct
experi
vivo
adapt
accord
us
nih
award
rsb
work
studi
agreement
receipt
exempt
us
govern
statement
fund
paus
certain
type
gof
research
data
support
find
studi
avail
correspond
author
request
